News

In this episode of JACC This Week, Dr. Harlan M. Krumholz and Dr. Carolyn S.P. Lam discuss a dedicated issue of JACC focused on cardiac amyloidosis—one of the…

Minimally invasive skin biopsies may be used to diagnose transthyretin amyloidosis and guide treatment in people with the rare progressive disease, according to the…

ORLANDO, Fla. (Ivanhoe Newswire) --- Cardiac amyloidosis is a systemic disorder that affects the heart and can also affect other organs such as the kidneys and…

Cardiac amyloidosis (CA) is present in approximately 10% of patients with heart failure worldwide, with wild-type transthyretin-mediated amyloid cardiomyopathy (…

Aerska, a startup developing treatments to silence the problematic genes that cause various brain diseases, has raised $39 million in financing, it told STAT…

ransthyretin (TTR) amyloid cardiomyopathy (ATTR-CM) is a progressive, often fatal disease. TTR stabilizers bind directly to TTR, inhibiting tetramer dissociation…

bstractATTR amyloidosis patient with initial atrial capture failure showed delayed threshold improvement over time. Stable current of injury and impedance guided…

BackgroundElvis, Joe’s son in law, has been diagnosed with a rare and serious kidney disease called MGRS (Monoclonal Gammopathy of Renal Significance) —…

Harvard Medical School’s (HMS) UDN and Countway Library of Medicine are very excited to invite you to our 2026 February Rare Disease Month Programming. For the most…

A rare and potentially fatal form of heart disease known as transthyretin amyloid cardiomyopathy, or ATTR-CM, is increasingly drawing clinical attention as…